Difference between revisions of "Team:HZAU-China/Collaborations"
| (5 intermediate revisions by 2 users not shown) | |||
| Line 725: | Line 725: | ||
use this system in their own projects. In the past two years, we have spent a great deal of time | use this system in their own projects. In the past two years, we have spent a great deal of time | ||
using it in our projects and accumulated a lot of experience (see more information in our previous | using it in our projects and accumulated a lot of experience (see more information in our previous | ||
| − | wikis). This year, we collaborated with WHU-China and SDU-CHINA who use this system in | + | wikis). This year, we collaborated with WHU-China and SDU-CHINA who use this system in their projects and |
sharing the experience how we regulated the expression of CcaS and CcaR protein to control this | sharing the experience how we regulated the expression of CcaS and CcaR protein to control this | ||
optogenetic tool and what we achieved. | optogenetic tool and what we achieved. | ||
| Line 755: | Line 755: | ||
the IL7-AS has tissue specificity to distinguish between cancer cells and healthy cells or not. | the IL7-AS has tissue specificity to distinguish between cancer cells and healthy cells or not. | ||
Secondly, we want to explore its applicability for which this biomarker can be widely utilized to | Secondly, we want to explore its applicability for which this biomarker can be widely utilized to | ||
| − | detect tumours. The Worldshaper-Wuhan team successfully demonstrated that IL7-AS has | + | detect tumours. The Worldshaper-Wuhan team successfully demonstrated that IL7-AS has specificity and |
universality. There were significant expression differences among 293T (the healthy cell), 769-P | universality. There were significant expression differences among 293T (the healthy cell), 769-P | ||
(the adenocarcinoma cell) and 786-O (the adenocarcinoma cell) cell lines. The expression in 769-P | (the adenocarcinoma cell) and 786-O (the adenocarcinoma cell) cell lines. The expression in 769-P | ||
| − | and 786-O were higher than that of 293T, showing | + | and 786-O were higher than that of 293T, showing specificity and universality of IL7-AS. Through our |
team's suggestions and Worldshaper-Wuhan's experiment, their project improved and we also got a new | team's suggestions and Worldshaper-Wuhan's experiment, their project improved and we also got a new | ||
biomarker | biomarker | ||
| Line 820: | Line 820: | ||
<div class="h1">Collaboration with HUST-China</div> | <div class="h1">Collaboration with HUST-China</div> | ||
| − | <p> | + | <p>When we submitted our parts, we got the help of HUST-China. HUST-China |
| − | helped us | + | helped us freeze the plasmid into dry powder in 96 well plate format, label our plate with our team name and |
| − | submission number, and eventually send it by express. | + | submission number, and eventually send it by express to the agency in China. We are extremely grateful for their help. |
</p> | </p> | ||
| Line 844: | Line 844: | ||
meeting, we had friendly communications with many iGEMers and gained a lot of advice during this | meeting, we had friendly communications with many iGEMers and gained a lot of advice during this | ||
meetup. They suggested more possible delivery vehicles to our project and a more logical poster | meetup. They suggested more possible delivery vehicles to our project and a more logical poster | ||
| − | design. We took part in a quiz competition and were | + | design. We took part in a quiz competition and were awarded the prize for best collaboration quiz |
| − | with our buddy team SFLS_Shenzhen. After the meetup, we still | + | with our buddy team SFLS_Shenzhen. After the meetup, we're still talking on WeChat. |
</p> | </p> | ||
| Line 863: | Line 863: | ||
<div class="h1">CCiC meeting</div> | <div class="h1">CCiC meeting</div> | ||
<p>In August, we participated in the biggest iGEMer communication conference in China——Conference of | <p>In August, we participated in the biggest iGEMer communication conference in China——Conference of | ||
| − | China iGEMer Community (CCiC).During this meeting we communicated with teams tracking on therapy | + | China iGEMer Community (CCiC). During this meeting, we communicated with teams tracking on therapy and reflected more about our project. For further collaboration，we met the captain of WHU-China and |
| − | + | ||
talked about the experience of our optogenetic tool.</p> | talked about the experience of our optogenetic tool.</p> | ||
Latest revision as of 20:37, 17 October 2018
Optogenetic tool has broad prospects on synthetic biology, and the CcaS-CcaR system, which is developed from cyanobacteria has made obvious achievements, thus more and more teams are willing to use this system in their own projects. In the past two years, we have spent a great deal of time using it in our projects and accumulated a lot of experience (see more information in our previous wikis). This year, we collaborated with WHU-China and SDU-CHINA who use this system in their projects and sharing the experience how we regulated the expression of CcaS and CcaR protein to control this optogenetic tool and what we achieved.
We cooperated with the high school team, Worldshaper-Wuhan. We shared some information about our project and had several discussions then determined to have an experiment about the lncRNA IL7-AS in multiple cell lines. LncRNA IL7-AS is a newly discovered lncRNA, which might be a potential diagnostic biomarker and therapeutic target for renal cell carcinoma. Through this experiment, firstly, we want to know if the IL7-AS has tissue specificity to distinguish between cancer cells and healthy cells or not. Secondly, we want to explore its applicability for which this biomarker can be widely utilized to detect tumours. The Worldshaper-Wuhan team successfully demonstrated that IL7-AS has specificity and universality. There were significant expression differences among 293T (the healthy cell), 769-P (the adenocarcinoma cell) and 786-O (the adenocarcinoma cell) cell lines. The expression in 769-P and 786-O were higher than that of 293T, showing specificity and universality of IL7-AS. Through our team's suggestions and Worldshaper-Wuhan's experiment, their project improved and we also got a new biomarker and therapeutic target for future projects.
After the information we got from meetings and public investigation, we thought it’s necessary to enhance the targeting of engineered Salmonella we used, we designed a fuse protein which called OmpA-RGD to achieve this goal. RGD is a well-studied tumor homing tripeptide that specifically binds to alpha v beta 3 (αvβ3) integrin, which is widely overexpressed on cancer cells. So there’s a cell line called MDA-MB-231 surface displaying αvβ3 needed for our further targeting and safety experiments, with the great help of NAU-CHINA , we had channels to get this cell line from Shanghai Institute of Biochemistry and Cell Biology.
When we submitted our parts, we got the help of HUST-China. HUST-China helped us freeze the plasmid into dry powder in 96 well plate format, label our plate with our team name and submission number, and eventually send it by express to the agency in China. We are extremely grateful for their help.
We also took part in the iGEM EurAisan Meetup, where we shared our ideas and learned a lot. At the meeting, we had friendly communications with many iGEMers and gained a lot of advice during this meetup. They suggested more possible delivery vehicles to our project and a more logical poster design. We took part in a quiz competition and were awarded the prize for best collaboration quiz with our buddy team SFLS_Shenzhen. After the meetup, we're still talking on WeChat.
In August, we participated in the biggest iGEMer communication conference in China——Conference of China iGEMer Community (CCiC). During this meeting, we communicated with teams tracking on therapy and reflected more about our project. For further collaboration，we met the captain of WHU-China and talked about the experience of our optogenetic tool.
